Back to Search Start Over

Effectiveness and Safety of A Nutraceutical Formulation for the Treatment of Functional Dyspepsia in Primary Care

Authors :
Giuseppe Sica
Maria Santa Alfieri
Antonio Pio Palieri
Pasquale Zecchillo
Luigi Mazzilli
Antonio Tursi
Francesco Detommasi
Fabrizio Bossa
Marcello Picchio
Giovanni Brandimarte
Leonardo Allegretta
Vincenzo De Cristofaro
Giovanni Sbarra
Michele Manfredi
Giovanni Messa
Antonio Penna
Pietro Derenzio
Basilio Paolo Colucci
Rocco Demauro
Saverio Nappi
Michele Fazio
Francesco Maurichi
Federica Greco
Francesco Monterisi
Alessio Gallo
Mario Tarallo
Pasquale Bellomo
Costantino Vigilante
Vito Lisco
Walter Elisei
Vincenzo Ferrari
Francesco Lore
Pasquale Saponaro
Antonio Elefante
Natale Antonino
Giorgio Marsano
Giancarlo Torelli
Anna Rosa Resta
Carlo Autorino
Ludovico Abenavoli
Giuseppe Pranzo
Simone Di Bella
Giulio Minoretti
Pierluigi Benedicenti
Stefano Gallina
Carlo Casamassima
Pasquale Mascoli
Salvatore Scutifero
Giovanni Luca Rizzo
Donatella Greco
Pasquale Misciagna
Vincenzo Selvaggio
Source :
Reviews on Recent Clinical Trials. 16:329-334
Publication Year :
2021
Publisher :
Bentham Science Publishers Ltd., 2021.

Abstract

Background: Although FD may affect up to 10% of the general population, the therapy for FD is not standard. Recently, ginger-based food supplements have been proposed in order to restore FD symptoms. Our aim was to assess the efficacy of a new nutraceutical formulation containing extract of gingerol and thymus as a possible natural treatment in managing the symptoms of functional dyspepsia (FD). Methods: We retrospectively analyzed the efficacy and safety profiles of a nutraceutical formulation containing Zingiber officinalis root extract and a standardized Thymus extract. It was administered as 1 ml/day twice a day for 90 days. Patients were assessed at baseline and after 1, 2 and 3 months of treatment, following a month of pharmacological washout by completing a questionnaire reporting the trend of the following symptoms: epigastric pain, epigastric heaviness, early satiety, belching, and regurgitation. Every symptom was assessed by a Visual Analogic Scale (VAS), ranging from 0= absence to 10= maximal severity. Results: We enrolled 272 patients (99 males and 173 females; median IQR age 49.5, 36-64 yrs). Obesity (BMI>30) was present in 28 (12.5%) patients; smokers were 83 (30.5%); and comorbidities were present in 107 (39.3%) patients. Improvement of symptom scores during treatment and one month after its suspension was extremely significant (p Conclusion: This large study found that nutraceutical formulation could be one of the tools for an empirical approach to treat patients with FD, especially when a non-conventional drug treatment is preferable for the patient and considered suitable by the physician.

Details

ISSN :
15748871
Volume :
16
Database :
OpenAIRE
Journal :
Reviews on Recent Clinical Trials
Accession number :
edsair.doi.dedup.....708c3cecbfe5cc4ea2e5d7260a57006e
Full Text :
https://doi.org/10.2174/1574887116666210612034911